Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
04/01/1998 | EP0831866A1 Pineal gland specific gene-1 |
04/01/1998 | EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
04/01/1998 | EP0831852A1 Nucleosides with anti-hepatitis b virus activity |
04/01/1998 | EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides |
04/01/1998 | EP0831846A1 Capped synthetic rna, analogs, and aptamers |
04/01/1998 | EP0831819A1 Method for inhibiting neoplastic disease in mammals |
04/01/1998 | EP0831812A2 Methods and compositions for stimulating neurite growth |
04/01/1998 | EP0831806A1 Multidentate metal complexes and methods of making and using thereof |
04/01/1998 | EP0831793A1 Protein particles for therapeutic and diagnostic use |
04/01/1998 | EP0831792A2 Apparatus and method for delivering a biologically active compound into a biological environment |
04/01/1998 | EP0831791A1 Delivery of drugs to the lower gi tract |
04/01/1998 | EP0831787A2 Composition for sustained release of human growth hormone |
04/01/1998 | EP0831786A2 Device for releasing aggregation-stabilized, biologically active agent |
04/01/1998 | EP0831782A1 Methods and system for processing dispersible fine powders |
04/01/1998 | EP0831773A1 Peptide/protein suspended formulations |
04/01/1998 | EP0831769A2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
04/01/1998 | EP0831752A1 A device for delivering a preselected molecule into the system circulation |
04/01/1998 | EP0771555A4 Agent for external application with nutrient and protective properties |
04/01/1998 | EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
04/01/1998 | EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis |
04/01/1998 | CN1177965A 角质形成细胞生长因子-2 Keratinocyte growth factor-2 |
04/01/1998 | CN1177928A Generation of human insulin |
04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
04/01/1998 | CN1177500A Film for preventing and treating hyperplastic scar and preparation method thereof |
03/31/1998 | US5734082 Hydroxyethyl aminimides |
03/31/1998 | US5734081 Arylthio compounds |
03/31/1998 | US5734049 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
03/31/1998 | US5734039 Antisense oligonucleotides targeting cooperating oncogenes |
03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
03/31/1998 | US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase |
03/31/1998 | US5734033 Antisense oligonucleotides inhibiting human bcl-2 gene expression |
03/31/1998 | US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
03/31/1998 | US5734024 Method for determining the biological activity of recombinant human growth hormone |
03/31/1998 | US5734023 Contacting isolated major histocompatibility complex chain component with an autoantigenic peptide such that the peptide is coupled to the antigen binding site to form a complex |
03/31/1998 | US5734022 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
03/31/1998 | US5734018 Biosynthesis detection, analyzing method to obtain peptide sequences |
03/31/1998 | US5734016 Genetic engineering |
03/31/1998 | US5734015 Antibiotics |
03/31/1998 | US5734014 Polypeptide |
03/31/1998 | US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
03/31/1998 | US5734012 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
03/31/1998 | US5733933 Methods and materials for the diagnosis and treatment of conditions such as stroke |
03/31/1998 | US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
03/31/1998 | US5733885 Heat treatment of blood for safety |
03/31/1998 | US5733884 Enteral formulation designed for optimized wound healing |
03/31/1998 | US5733881 Analgesics, immunosuppressants |
03/31/1998 | US5733880 Anthracene derivatives for use as anticancer agents |
03/31/1998 | US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors |
03/31/1998 | US5733878 Morphogen-induced periodontal tissue regeneration |
03/31/1998 | US5733877 Pharmaceutical composition containing biologically active peptide or protein |
03/31/1998 | US5733876 Method of inhibiting angiogenesis |
03/31/1998 | US5733875 Epilepsy |
03/31/1998 | US5733874 Stable dry powders |
03/31/1998 | US5733873 Polyoxamers or polyoxyethylene sorbitan fatty acid esters with sodium chloride, calcium chloride, histidine or sugars |
03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
03/31/1998 | US5733871 Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
03/31/1998 | US5733870 Ointment for treatment of epithelial lesions |
03/31/1998 | US5733869 Systemically administering stroma-free hemoglobin to a patient experiencing ventricular fibrillation during cardiac pulmonary resuscitation, and defibrillation to effect return of spontaneous cirulation in the patient |
03/31/1998 | US5733790 CRF binding protein antibodies and assays using same |
03/31/1998 | US5733781 Dna and human immunodefficiency virus inhibitors |
03/31/1998 | US5733763 Containing cellulose fibers; stability; flexibility; sustained release |
03/31/1998 | US5733761 Gene therapy |
03/31/1998 | US5733760 Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof |
03/31/1998 | US5733748 Isolated polynucleotide; cancer diagnosis |
03/31/1998 | US5733742 Polyclonal immunoglobulin fab fragments |
03/31/1998 | US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
03/31/1998 | US5733730 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
03/31/1998 | US5733569 Drugs for nasal administering |
03/31/1998 | US5733562 Injectable medical device and method of use |
03/31/1998 | US5733550 Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin |
03/31/1998 | US5733548 Stimulating t-cell response |
03/31/1998 | US5733547 Treatment of autoimmune arthritis by oral administration of type I or type III collagen |
03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
03/31/1998 | US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset |
03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
03/31/1998 | US5733524 Screening for neuroprotective agents by administering them with infarct-producing amine compounds, then comparing responses in treated and untreated animals |
03/31/1998 | US5733446 Centrifuge with annular filter |
03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
03/31/1998 | CA2040441C Fusion proteins |
03/31/1998 | CA1339793C Cyclic analogs of atrial natriuretic peptides |
03/31/1998 | CA1339791C Human nerve growth factor |
03/26/1998 | WO1998012347A1 Rh blood group antigen compositions and methods of use |
03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
03/26/1998 | WO1998012330A1 Mammalian cytokine, related reagents |
03/26/1998 | WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
03/26/1998 | WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use |
03/26/1998 | WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins |
03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
03/26/1998 | WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor |
03/26/1998 | WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto |
03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
03/26/1998 | WO1998012320A1 Nucleic acid construct coding for a protein complex from a stat protein and a nuclear receptor and its use |
03/26/1998 | WO1998012319A1 Broad spectrum therapeutic peptide |
03/26/1998 | WO1998012318A1 Thrombin inhibitor |
03/26/1998 | WO1998012317A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents |